Cargando…
Serum N‐Terminal Type III Procollagen Propeptide: An Indicator of Growth Hormone Excess and Response to Treatment in Feline Hypersomatotropism
BACKGROUND: N‐terminal type III procollagen propeptide (PIIINP) is a biomarker of soft tissue proliferation. Hypersomatotropism (HS) is associated with soft tissue proliferation. HYPOTHESIS: Serum PIIINP is increased in cats with HS and decreases with effective treatment, and may be an additional to...
Autores principales: | Keyte, S.V., Kenny, P.J., Forcada, Y., Church, D.B., Niessen, S.J.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108467/ https://www.ncbi.nlm.nih.gov/pubmed/27425382 http://dx.doi.org/10.1111/jvim.14373 |
Ejemplares similares
-
Pasireotide for the Medical Management of Feline Hypersomatotropism
por: Scudder, C.J., et al.
Publicado: (2015) -
Pasireotide Long‐Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism
por: Gostelow, R., et al.
Publicado: (2017) -
Hypersomatotropism in 3 Cats without Concurrent Diabetes Mellitus
por: Fletcher, J.M., et al.
Publicado: (2016) -
Efficacy of hypophysectomy for the treatment of hypersomatotropism‐induced diabetes mellitus in 68 cats
por: Fenn, Joe, et al.
Publicado: (2021) -
Evaluation and Diagnostic Potential of Serum Ghrelin in Feline Hypersomatotropism and Diabetes Mellitus
por: Jensen, K.B., et al.
Publicado: (2015)